| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 78.28M | 82.34M | 82.53M | 60.84M | 36.36M |
| Gross Profit | 67.38M | 74.85M | 9.17M | 50.79M | 935.00K |
| EBITDA | 12.29M | 14.37M | 12.62M | 8.83M | 2.71M |
| Net Income | 6.37M | 7.72M | 7.89M | 4.17M | 113.00K |
Balance Sheet | |||||
| Total Assets | 79.11M | 80.55M | 75.87M | 64.30M | 54.57M |
| Cash, Cash Equivalents and Short-Term Investments | 10.10M | 13.93M | 14.66M | 19.05M | 14.00M |
| Total Debt | 550.00K | 1.01M | 730.00K | 409.00K | 433.00K |
| Total Liabilities | 17.85M | 20.61M | 19.23M | 21.62M | 17.43M |
| Stockholders Equity | 61.26M | 59.94M | 56.65M | 42.68M | 37.14M |
Cash Flow | |||||
| Free Cash Flow | 645.00K | 3.07M | -731.00K | 6.00M | -1.47M |
| Operating Cash Flow | 3.65M | 8.47M | 3.97M | 9.75M | 987.00K |
| Investing Cash Flow | -3.10M | -296.00K | -5.74M | -3.71M | -2.41M |
| Financing Cash Flow | -4.38M | -3.85M | -3.68M | -1.73M | -411.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £51.79M | 7.66 | 14.20% | 10.69% | -7.42% | -42.84% | |
74 Outperform | £53.30M | 8.40 | 19.42% | 0.57% | 2.64% | 23.89% | |
70 Neutral | £63.56M | 47.22 | 3.37% | 1.52% | 9.26% | 31.71% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £39.04M | 8.14 | 8.35% | 7.13% | -3.45% | -35.25% | |
47 Neutral | £14.13M | 162.70 | 0.17% | 3.41% | -3.72% | ― | |
45 Neutral | £34.26M | ― | -19.58% | 3.02% | -4.23% | -435.86% |
Churchill China reported a challenging first half of 2025, with revenue decreasing by 5.2% to £38.5 million. The company faced significant headwinds in the hospitality sector, including increased labor costs and weak consumer sentiment, which impacted profitability. Despite these challenges, Churchill China maintained stable market share and focused on operational efficiency and automation investments to counteract cost pressures. The company remains optimistic about medium-term market recovery and continues to prioritize maintaining a healthy cash balance.